Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
|Articles|December 17, 2021
News Roundup: ASH Annual Meeting, Drug Topics Year in Review
Here’s a roundup of the latest news from Drug Topics®.
Advertisement
Year in Review: 2021 Top News from Drug Topics®
Best of the Best: Sidrah Alam on Her Road to Pharmacy School
New Drug Review: Atogepant FDA-Approved for Migraine Treatment
Probiotics Can Help Treat Candidiasis, Study Shows
New Drug Approvals in Pediatrics
Slow Going: Progress to Resolve Drug Supply Chain Issues Is Minimal
Profits Soar, But Pay Stays the Same: Chain Pharmacists Are Ready to Speak Up
COVID-19 Infection, Vaccination Outcomes in Explored at ASH Annual Meeting
Advertisement
Related to this article
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026
3
FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026
4
Pharmacists Step Up on Test-To-Treat This American Pharmacist Month
5